Video

Watch | Should you subscribe to Tatva Chintan Pharma Chem IPO?

BL Internet Desk | Updated on July 17, 2021

Tatva Chintan Pharma Chem (Tatva Chintan) incorporated in the year 1996 is a speciality chemicals manufacturer, producing a range of products across Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Pharmaceutical and Agrochemical intermediates and other Specialty Chemicals (PASC), and electrolyte salts .

The IPO which is open for subscription till July 20, aims to raise a total of ₹500 crore with an offer for sale of ₹275 crore , and a fresh issue of ₹225 crore.

Watch to know more.

Published on July 17, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.